Page last updated: 2024-12-11
1-geranylazacycloheptan-2-one
Description
1-Geranylazacycloheptan-2-one is a synthetic compound that doesn't seem to have widespread recognition or research associated with it. This means:
* **It's unlikely to be a well-established or widely studied compound.** It's possible this name is not standard or has been used in a very specialized field.
* **There might be a typo in the name.** A small error in spelling or structure could result in a name that doesn't match any known compound.
**To get more information, I need more context:**
1. **Where did you encounter this name?** Was it in a scientific paper, a textbook, or another source?
2. **What kind of research are you interested in?** This will help me understand what you're looking for.
**For example, if you're looking for information about a related compound, please provide:**
* **The context:** What is the compound being used for? What research area is it related to?
* **Any other information:** Do you know its structure, its function, or its potential applications?
With more information, I can better assist you in finding the information you need.
1-geranylazacycloheptan-2-one: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 6441192 |
SCHEMBL ID | 121994 |
SCHEMBL ID | 121342 |
MeSH ID | M0186640 |
Synonyms (14)
Synonym |
1-gacho |
1-[(2e)-3,7-dimethylocta-2,6-dienyl]azepan-2-one |
110261-29-5 |
1-geranylazacyclohepan-2-one |
117694-76-5 |
2h-azepin-2-one, 1-(3,7-dimethyl-2,6-octadienyl)hexahydro- |
1-geranylazacycloheptan-2-one |
SCHEMBL121994 |
SCHEMBL121342 |
n-(3,7-dimethyl-2,6-octadienyl)-caprolactam |
1-(3,7-dimethylocta-2,6-dien-1-yl)azepan-2-one |
l-geranylazacycloheptan-2-one |
1-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]azepan-2-one |
DTXSID101347783 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.66 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.45 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |